T.W.J. Huizinga
Universiteit Leiden
H-index: 153
Europe-Netherlands
Top articles of T.W.J. Huizinga
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
P31 A novel disease endotype in SLE characterized by B cell hyperactivity, Sm/RNP reactivity and higher disease activity | Hugo J van Dooren Yemil Atisha-Fregoso Annemarie L Dorjée Tom WJ Huizinga Meggan Mackay | 2024/3/1 | |
Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome | Rodrigo Aguirre Del-Pino Rory C Monahan Tom WJ Huizinga Jeroen Eikenboom Gerda M Steup-Beekman | 2024/1/16 | |
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial | The Lancet | Andrew P Cope Marianna Jasenecova Joana C Vasconcelos Andrew Filer Karim Raza | 2024/2/13 |
Does a history of smoking increase the risk of developing systemic sclerosis? Insights from the Leiden systemic sclerosis cohort | Rheumatology Advances in Practice | Jacopo Ciaffi Sophie IE Liem Suzanne C Cannegieter Saad Ahmed Eva Hoekstra | 2024/4/16 |
Can Pharmacological Conditioning as an Add-On Treatment Optimize Standard Pharmacological Treatment in Patients with Recent-Onset Rheumatoid Arthritis? A Proof-of-Principle … | Pharmaceuticals | Meriem Manaï Henriët van Middendorp Joy A van der Pol Cornelia F Allaart Elise Dusseldorp | 2024/1/13 |
Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis | Nature Communications | Eva Maria Stork Danique MH van Rijswijck Karin A van Schie Max Hoek Theresa Kissel | 2024/4/10 |
Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time? | Annals of the rheumatic diseases | Lotte van Ouwerkerk Patrick Verschueren Maarten Boers Paul Emery Pascal Hendrik Pieter de Jong | 2024/1/1 |
Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohort | Annals of the Rheumatic Diseases | Sascha Louise Heckert Johanna Maria Maassen S le Cessie YPM Goekoop-Ruiterman Melek Güler-Yüksel | 2024/2/1 |
Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study | RMD open | Joy Ardjuna van der Pol Cornelia F Allaart Willem Lems Sjoerd M van der Kooij Tom WJ Huizinga | 2024/4/1 |
Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily … | Seminars in Arthritis and Rheumatism | L van Ouwerkerk SA Bergstra TD Maarseveen TWJ Huizinga R Knevel | 2024/2/1 |
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023 | Annals of the rheumatic diseases | Kevin L Winthrop Philip Mease Andreas Kerschbaumer Reinhard E Voll Ferdinand C Breedveld | 2024/4/1 |
IgM antibodies against acetylated proteins as a possible starting point of the anti-modified protein antibody response in rheumatoid arthritis | Annals of the Rheumatic Diseases | Tineke J van Wesemael Sanne Reijm Atsushi Kawakami Annemarie L Dorjée Gerrie Stoeken | 2024/2/1 |
High prevalence but low impact of cognitive dysfunction on quality of life in patients with lupus and neuropsychiatric symptoms | Arthritis Care & Research | Rory C Monahan Huub AM Middelkoop Liesbeth JJ Beaart‐van de Voorde Rolf Fronczek Rolf HH Groenwold | 2023/5 |
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis | Annals of the rheumatic diseases | Lotte van Ouwerkerk Maarten Boers Paul Emery Pascal HP de Jong Robert BM Landewé | 2023/4/1 |
POS1251 TREATMENT TAPERING IN SYSTEMIC SCLEROSIS: A 10-YEAR FOLLOW-UP STUDY | J Ciaffi S Liem N Van Leeuwen C Allaart T Huizinga | 2023/6/1 | |
AB0892 SMOKING DOES NOT REPRESENT A SUSCEPTIBILITY FACTOR FOR THE DEVELOPMENT OF SYSTEMIC SCLEROSIS: AN ANALYSIS OF THE LEIDEN CCISS COHORT | J Ciaffi S Liem T Huizinga J De Vries-Bouwstra | 2023/6/1 | |
Response to biologic drugs in patients with rheumatoid arthritis and antidrug antibodies | JAMA Network Open | Samuel Bitoun Signe Hässler David Ternant Natacha Szely Aude Gleizes | 2023/7/3 |
The long-term course of the Health Assessment Questionnaire in patients with systemic sclerosis | Journal of Scleroderma and Related Disorders | Sophie IE Liem Sytske Anne Bergstra Jacopo Ciaffi Coen van der Meulen David A Ueckert | 2023/10 |
In rheumatoid arthritis patients, total IgA1 and IgA2 levels are elevated: implications for the mucosal origin hypothesis | Rheumatology | Veerle FAM Derksen Cornelia F Allaart Annette HM Van der Helm-Van Mil Tom WJ Huizinga René EM Toes | 2023/1/1 |
The effect of silver fibre gloves on Raynaud’s phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial | Rheumatology | Sophie IE Liem Eva M Hoekstra Femke Bonte-Mineur César Magro Checa Anne Schouffoer | 2023/2/1 |
